KALV
NASDAQStockKalVista Pharmaceuticals, Inc.
$16.88-0.51 (-2.91%)
52-Week Range
$10.32
$18.44
Key Stats
Market Cap
853.0M
P/E Ratio
—
Dividend Yield
—
Beta
-0.29
Volume
683.6K
Avg Volume
922.1K
Performance
1M
+14.95%
3M
+2.84%
6M
+27.61%
YTD
+12.42%
1Y
+37.94%
3Y
+133.29%
5Y
-47.35%
Price Chart
ETF Exposure
KALV is held by 81 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| BBP | Virtus Biotech ETF | 1.64% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.61% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.58% |
| VFLQ | Vanguard U.S. Liquidity Factor ETF | 0.57% |
| CURE.AX | Global X - S&P Biotech ETF | 0.25% |
| XBI | State Street SPDR S&P Biotech ETF | 0.25% |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 0.18% |
| IWC | iShares Micro-Cap ETF | 0.14% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.07% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.07% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.07% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.06% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.06% |
| IBB | iShares Biotechnology ETF | 0.06% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.06% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.05% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.05% |
| IWO | iShares Russell 2000 Growth ETF | 0.05% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.04% |
| PWS | Pacer WealthShield ETF | 0.04% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.04% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.04% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.02% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.02% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.02% |
| RSSL | Global X - Russell 2000 ETF | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.02% |
| UWM | ProShares - Ultra Russell2000 | 0.02% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| CUS1.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| CUSS.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| SXRG.DE | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| WDSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| WOSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| ZPRS.DE | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
Page 1 of 2Next
About KALV ETF Exposure
KalVista Pharmaceuticals, Inc. (KALV) is held by 81 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 853.0M, KALV is a widely held institutional stock. The stock currently trades at $16.88. Investors can gain exposure to KALV through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KALV, sorted by portfolio weight.